The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro
Open accessAbstract
Banisteriopsis caapi is the basic ingredient of ayahuasca, a psychotropic plant tea used in the Amazon for ritual and medicinal purposes, and by interested individuals worldwide. Animal studies and recent clinical research suggests that B. caapi preparations show antidepressant activity, a therapeutic effect that has been linked to hippocampal neurogenesis. Here we report that harmine, tetrahydroharmine and harmaline, the three main alkaloids present in B. caapi, and the harmine metabolite harmol, stimulate adult neurogenesis in vitro. In neurospheres prepared from progenitor cells obtained from the subventricular and the subgranular zones of adult mice brains, all compounds stimulated neural stem cell proliferation, migration, and differentiation into adult neurons. These findings suggest that modulation of brain plasticity could be a major contribution to the antidepressant effects of ayahuasca. They also expand the potential application of B. caapi alkaloids to other brain disorders that may benefit from stimulation of endogenous neural precursor niches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings from in vitro and in vivo studies show that these compounds stimulate neurogenesis, BDNF, and have antidepressant effects (70–73).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in vitro, animal and human studies have demonstrated how harmine, tetrahydroharmine, harmaline (all three present in B. caapi) and dimethyltryptamine (present in P. viridis) stimulate adult neurogenesis and neuroplasticity, similarly to other serotoninergic psychedelic substances (40–43).”
From Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol (2025) · cites this paper as [42]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Neuronal replacement from endogenous precursors in the adult brain after stroke
Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., & Lindvall, O. (2002) · Nature Medicine · doi:10.1038/nm747 · Cited by 2,799
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
Álvarez-Buylla, A., & Lim, D. A. (2004) · Neuron · doi:10.1016/s0896-6273(04)00111-4 · Cited by 1,348
Adult Neurogenesis in the Hippocampus: From Stem Cells to Behavior
Gonçalves, J. T., Schafer, S. T., & Gage, F. H. (2016) · Cell · doi:10.1016/j.cell.2016.10.021 · Cited by 1,122
Dopamine depletion impairs precursor cell proliferation in Parkinson disease
Höglinger, G. U., Rizk, P., Mp, M., Duyckaerts, C. J., Oertel, W. H., Caillé, I., & Hirsch, É. C. (2004) · Nature Neuroscience · doi:10.1038/nn1265 · Cited by 974
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723
Antidepressants increase neural progenitor cells in the human hippocampus
Boldrini, M., Underwood, M. D., Hen, R., Rosoklija, G. B., Dwork, A. J., John Mann, J., & Arango, V. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.75 · Cited by 686
Cited by
Sorted by citations
Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osório, F. L., Sanches, R., dos Santos, R. G., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718001356 · Cited by 852
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Schlag, A. K., Aday, J. S., Salam, I., Neill, J. C., & Nutt, D. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069100 · Cited by 359
de Vos, C. M. H., Mason, N. L., & Kuypers, K. P. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.724606 · Cited by 269
Psychedelics as anti-inflammatory agents
Flanagan, T. W., & Nichols, C. D. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1481827 · Cited by 267
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Raval, N. R., Johansen, A., Donovan, L. L., Ros, N. F., Ozenne, B., Hansen, H. D., & Knudsen, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020835 · Cited by 200
Almeida, R. N. D., Galvão, A. C. D. M., da Silva, F. S., Silva, E. A. D. S., Palhano-Fontes, F., Maia-de-Oliveira, J. P., de Araújo, L.-S. B., Lobão-Soares, B., & Galvão-Coelho, N. L. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01234 · Cited by 177
Miller, M. J., Albarracín-Jordán, J., Moore, C. M., & Capriles, J. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902174116 · Cited by 172
Morales-Garcia, J. A., Calleja-Conde, J., Lopez-Moreno, J. A., Alonso-Gil, S., Sanz-SanCristobal, M., Riba, J., & Perez-Castillo, A. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01011-0 · Cited by 138
Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers
Hutten, N. R. P. W., Mason, N. L., Dolder, P. C., Theunissen, E. L., Holze, F., Liechti, M. E., Varghese, N., Eckert, A., Feilding, A., Ramaekers, J. G., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00099 · Cited by 131
Self-citationdos Santos, R. G., & Hallak, J. E. C. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.001 · Cited by 111
Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis
Bharate, S. S., Mignani, S., & Vishwakarma, R. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01922 · Cited by 102
Soler, J., Elices, M., Dominguez-Clavé, E., Pascual, J. C., Feilding, A., Navarro-Gil, M., García-Campayo, J., & Riba, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00224 · Cited by 102
Self-citationDoes Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
Kočárová, R., Horáček, J., & Carhart-Harris, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.661233 · Cited by 96
Inserra, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00330 · Cited by 91
Lima da Cruz, R. V., Moulin, T. C., Petiz, L. L., & Leão, R. N. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00312 · Cited by 84
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy
Corrigan, K., Haran, M., McCandliss, C., McManus, R., Cleary, S., Trant, R., Kelly, Y., Ledden, K., Rush, G., O’Keane, V., et al. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02668-2 · Cited by 84
Chaurasiya, N. D., León, F., Muhammad, I., & Tekwani, B. L. (2022) · Molecules · doi:10.3390/molecules27134297 · Cited by 86
Kozłowska, U., Nichols, C. D., Wiatr, K., & Figiel, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15509 · Cited by 86
Renelli, M., Fletcher, J., Tupper, K. W., Files, N., Loizaga-Velder, A., & Lafrance, A. (2018) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-018-0619-6 · Cited by 83
Kong, Y. R., Tay, K. C., Su, Y. X., Wong, C. K., Tan, W., & Khaw, K. Y. (2021) · Molecules · doi:10.3390/molecules26030728 · Cited by 79
Biosynthesis and synthetic biology of psychoactive natural products
Jamieson, C. S., Misa, J., Tang, Y., & Billingsley, J. M. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00065a · Cited by 74
Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective
Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69
Weiss, F., Magnesa, A., Gambini, M., Gurrieri, R., Annuzzi, E., Elefante, C., Perugi, G., & Marazziti, D. (2025) · Brain Sciences · doi:10.3390/brainsci15020117 · Cited by 71
Psychedelic‐inspired approaches for treating neurodegenerative disorders
Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 72
Katchborian-Neto, A., Santos, W. T., Nicácio, K. J., Corrêa, J. O. A., Murgu, M., Martins, T. M. M., Gomes, D. A., Goes, A. M., Soares, M. G., Dias, D. F., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112743 · Cited by 62
Colaço, C. S., Alves, S. S., Nolli, L. M., Pinheiro, W. O., de Oliveira, D. G. R., Santos, B. W. L., Pic-Taylor, A., Mortari, M. R., & Caldas, E. D. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00547-w · Cited by 58
Oña, G., & Bouso, J. C. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.035 · Cited by 60
Estrada, M., Herrera‐Arozamena, C., de Andrés, L., Pérez, C., Morales-Garcia, J. A., Pérez‐Castillo, A., Ramos, E., Romero, A., Viña, D., Yáñez, M., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.026 · Cited by 56
Perkins, D., Pagni, B. A., Sarris, J. J., Barbosa, P. C. R., & Chenhall, R. D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.884703 · Cited by 63
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders
Lowe, H. I. C., Toyang, N. J., Steele, B., Grant, J., Ali, A., Gordon, L., & Ngwa, W. F. (2022) · Molecules · doi:10.3390/molecules27082520 · Cited by 58
Exploring DMT: Endogenous role and therapeutic potential
Schimmelpfennig, J., & Jankowiak-Siuda, K. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110314 · Cited by 55
Ayahuasca: A review of historical, pharmacological, and therapeutic aspects
Ruffell, S., Crosland‐Wood, M., Palmer, R., Netzband, N., Tsang, W., Weiss, B., Gandy, S., Cowley‐Court, T., Halman, A., McHerron, D., et al. (2023) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.146 · Cited by 61
Psychedelics and virtual reality: parallels and applications
Aday, J. S., Davoli, C. C., & Bloesch, E. K. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320948356 · Cited by 47
Ayahuasca's therapeutic potential: What we know – and what not
Maia, L. O., Daldegan‐Bueno, D., Wießner, I., de Araújo, D. B., & Tófoli, L. F. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.10.008 · Cited by 54
The pharmacological interaction of compounds in ayahuasca: a systematic review
Ruffell, S., Netzband, N., Bird, C., Young, A. H., & Juruena, M. F. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0884 · Cited by 57
Costa‐Machado, L. F., García-Domínguez, E., McIntyre, R. L., López-Aceituno, J. L., Ballesteros-Gonzalez, Á., Tapia-Gonzalez, A., Fabregat‐Safont, D., Eisenberg, T., Gómez, J., Plaza, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38410-y · Cited by 47
Kelley, D. P., Venable, K., Destouni, A., Billac, G., Ebenezer, P., Stadler, K., Nichols, C., Barker, S., & Francis, J. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00660 · Cited by 42
Eleftheriou, M. E., & Thomas, E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.707057 · Cited by 39
“Neurogenesis may also contribute to these effects, as psilocybin, ketamine as well as β-carbolines present in the ayahuasca brew, have all been shown to enhance neurogenesis in animal studies (42, 67, 68).”
BackgroundN,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine
James, E., Keppler, J., Robertshaw, T. L., & Sessa, B. (2022) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2835 · Cited by 50
Gonçalves, J., Luís, Â., Gallardo, E., & Duarte, A. P. (2021) · Molecules · doi:10.3390/molecules26051397 · Cited by 45
Estrada, M., Herrera‐Arozamena, C., Pérez, C., Viña, D., Morales-Garcia, J. A., Pérez‐Castillo, A., Ramos, E., Romero, A., Laurini, E., Pricl, S., et al. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1581184 · Cited by 39
Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review
Simão, A. Y., Gonçalves, J., Duarte, A. P., Barroso, M., Cristóvão, A. C., & Gallardo, E. (2019) · Medicines · doi:10.3390/medicines6040106 · Cited by 45
Catalysts for change: the cellular neurobiology of psychedelics
Banks, M. I., Zahid, Z., Jones, N., Sultan, Z. W., & Wenthur, C. J. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-05-0340 · Cited by 45
Berlowitz, I., Egger, K., & Cumming, P. D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.886408 · Cited by 40
Phosphodiesterase 7 Regulation in Cellular and Rodent Models of Parkinson’s Disease
Morales-Garcia, J. A., Alonso‐Gil, S., Santos, Á., & Pérez‐Castillo, A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01745-z · Cited by 37
Nootropic effects of LSD: Behavioral, molecular and computational evidence
Ornelas, I. M., da Silva, F. A. C., Wießner, I., Marcos, E., de Araújo, D. B., Goto‐Silva, L., Nascimento, J. M., Silva, S. R. B., Costa, M., Falchi-Carvalho, M., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114148 · Cited by 37
Egger, K., Aicher, H., Cumming, P. D., & Scheidegger, M. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05353-6 · Cited by 37
Santos, B. W. L., de Oliveira, R. C., Sonsin‐Oliveira, J., Fagg, C. W., Barbosa, J. B. F., & Caldas, E. D. (2020) · Plants · doi:10.3390/plants9070870 · Cited by 35
Neuropharmacological potentials of β-carboline alkaloids for neuropsychiatric disorders
Ayipo, Y. O., Mordi, M. N., Mustapha, M., & Damodaran, T. K. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173837 · Cited by 34
Rossi, G. N., Guerra, L. T. L., Baker, G. B., Dursun, S. M., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Biomolecules · doi:10.3390/biom12111618 · Cited by 33
Ghiasvand, M. K. H., Makhdoumi, A., Matin, M. M., & Vaezi, J. (2019) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-019-00410-z · Cited by 34
Socha, D. M., Sykutera, M., Reinhard, J., & Perea, R. C. (2022) · Journal of Archaeological Science Reports · doi:10.1016/j.jasrep.2022.103415 · Cited by 30
Stress, memory, and implications for major depression
de Sousa, G. M., Vargas, H. D. Q., Barbosa, F. F., & Coelho, N. L. G. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113410 · Cited by 32
Rush, B. R., Marcus, O., García, S., Loizaga-Velder, A. K., Loewinger, G. C., Spitalier, A., & Mendive, F. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.659644 · Cited by 32
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy
Orsolini, L., Chiappini, S., Papanti, D., Latini, R., Volpe, U., Fornaro, M., Tomasetti, C., Vellante, F., & Berardis, D. D. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2728 · Cited by 33
Ayahuasca Beverages: Phytochemical Analysis and Biological Properties
Gonçalves, J., Luís, Â., Gradillas, A., Garcı́a, A., Restolho, J., Fernández, N., Domingues, F., Gallardo, E., & Duarte, A. P. (2020) · Antibiotics · doi:10.3390/antibiotics9110731 · Cited by 29
Mosaffa, S., Ahmadi, H., Khakpai, F., Ebrahimi-Ghiri, M., & Zarrindast, M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05679-6 · Cited by 27
Santos, B. W. L., Moreira, D. C., Borges, T. K. D. S., & Caldas, E. D. (2022) · Molecules · doi:10.3390/molecules27082500 · Cited by 30
The potential of psychedelics for the treatment of Alzheimer's disease and related dementias
Winkelman, M., Szabó, A., & Frecska, E. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.07.003 · Cited by 33
Plant derived bioactive compounds and their potential to enhance adult neurogenesis
Krishnapriya, Sasikumar, P., Aswathy, M., Tripathi, P. P., Radhakrishnan, K. V., & Chakrapani, P. S. B. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100191 · Cited by 30
Herrera‐Arozamena, C., Estrada, M., López‐Caballero, P., Pérez, C., Morales-Garcia, J. A., Pérez‐Castillo, A., del Sastre, E., Fernández‐Mendívil, C., Duarte, P., Michalska, P., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01883 · Cited by 24
Werle, I., Nascimento, L. M. M., dos Santos, A. L. A., Soares, L. A., SANTOS, R. G. D., Hallak, J. E. C., & Bertoglio, L. J. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16315 · Cited by 28
Alkaloids as neuroprotectors: targeting signaling pathways in neurodegenerative diseases
Utpal, B., Amin, M. A., Zehravi, M., Sweilam, S. H., Arjun, U. V. N. V., Madhuri, Y., Gupta, J. K., Yaidikar, L., Tummala, T., Suseela, R., et al. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05258-3 · Cited by 19
Rehman, M. U., Zuo, Y., Tu, N., Guo, J., Liu, Z., Cao, S., & Long, S. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117350 · Cited by 23
Herrera‐Arozamena, C., Estrada, M., Pérez, C., Lagartera, L., Morales-Garcia, J. A., Pérez‐Castillo, A., Franco‐Gonzalez, J. F., Michalska, P., Duarte, P., Leon, R. M., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112090 · Cited by 23
Colaço, C. S., Alves, S. S., Nolli, L. M., Pinheiro, W. O., de Oliveira, D. G. R., Santos, B. W. L., Taylor, A. P., Mortari, M. R., & Caldas, E. D. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00854-w · Cited by 23
da Silva, M. G., Daros, G. C., & de Bitencourt, R. M. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113003 · Cited by 27
Can Psychedelic Drugs Attenuate Age-Related Changes in Cognition and Affect?
Aday, J. S., Bloesch, E. K., & Davoli, C. C. (2019) · Journal of Cognitive Enhancement · doi:10.1007/s41465-019-00151-6 · Cited by 23
Spee, B. T. M., Ishizu, T., Leder, H., Mikuni, J., Kawabata, H., & Pelowski, M. J. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.03.021 · Cited by 22
Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability
Rossi, G. N., Dias, I. C. D. S., Baker, G. B., Bouso, J. C., Dursun, S. M., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2054988 · Cited by 23
Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic Review
White, E., Kennedy, T., Ruffell, S., Perkins, D., & Sarris, J. J. (2024) · International Journal of Toxicology · doi:10.1177/10915818241230916 · Cited by 21
Evaluation of the Cytotoxicity of Ayahuasca Beverages
Simão, A. Y., Gonçalves, J., Gradillas, A., Garcı́a, A., Restolho, J., Fernández, N., Rodilla, J. M., Barroso, M., Duarte, A. P., Cristóvão, A. C., et al. (2020) · Molecules · doi:10.3390/molecules25235594 · Cited by 19
The current state of ayahuasca research in animal models: A systematic review
Daldegan‐Bueno, D., Simionato, N. M., Favaro, V. M., & Maia, L. O. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110738 · Cited by 21
Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review
da Cruz, R. V. L., Leão, R. N., & Moulin, T. C. (2024) · Molecular Medicine · doi:10.1186/s10020-024-01013-4 · Cited by 19
Politi, M., Friso, F., Rojas, G. S., & Romero, J. T. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1820641 · Cited by 18
Scheidegger, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_3 · Cited by 21
Harmine and its derivatives: Biological activities and therapeutic potential in human diseases
Javeed, M. H., Rasul, A., Hussain, G., Jabeen, F., Rasool, B., Riaz, A., Kaukab, G., & Ali, M. Z. (2018) · Bangladesh Journal of Pharmacology · doi:10.3329/bjp.v13i3.34990 · Cited by 18
Socha, D. M., Sykutera, M., & Orefici, G. (2022) · Journal of Archaeological Science · doi:10.1016/j.jas.2022.105688 · Cited by 17
Alves, C. L., Cury, R. G., Roster, K. I. O., Pineda, A. M., Rodrigues, F. A., Thielemann, C., & Ciba, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277257 · Cited by 17
Berlowitz, I., Torres, E. G., Maake, C., Wolf, U., & Martin-Söelch, C. (2023) · Plants · doi:10.3390/plants12020346 · Cited by 20
Psychedelic science in post-COVID-19 psychiatry
Kelly, J. R., Crockett, M. T., Alexander, L., Haran, M., Baker, A., Burke, L., Brennan, C., & O’Keane, V. (2020) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2020.94 · Cited by 16
Rossi, G. N., Hallak, J. E. C., Baker, G. B., Dursun, S. M., & SANTOS, R. G. D. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01460-2 · Cited by 16
Ayahuasca: Pharmacology, Safety, and Therapeutic Effects
SANTOS, R. G. D., & Hallak, J. E. C. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009585330.005 · Cited by 20
Oña, G., & Bouso, J. C. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191212103330 · Cited by 18
Velit-Salazar, M. R., Shiroma, P. R., & Cherian, E. (2024) · Brain Sciences · doi:10.3390/brainsci14030248 · Cited by 14
Fonseca, A. M., SANTOS, R. G. D., de Medeiros, L. S., Veiga, T. A. M., Cassas, F., Bruniera, C. P., Rossi, G. N., Bouso, J. C., Hallak, J. E. C., Santos, F. P., et al. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01817-9 · Cited by 13
Ayahuasca and Childhood Trauma: Potential Therapeutic Applications
Perkins, D., & Sarris, J. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_6 · Cited by 13
Levetiracetam promoted rat embryonic neurogenesis via NMDA receptor-mediated mechanism in vitro
Alavi, M. S., Negah, S. S., Ghorbani, A., Hosseini, A., & Sadeghnia, H. R. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119923 · Cited by 13
Nižňanský, Ľ., Nižnanská, Ž., Kuruc, R., Szórádová, A., Šikuta, J., & Zummerová, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11041147 · Cited by 13
Paes, A. S., Koga, R. D. C. R., Sales, P. F., Almeida, H. K. S., Teixeira, T. A., & Carvalho, J. C. T. (2023) · Molecules · doi:10.3390/molecules28176411 · Cited by 12
Microdosing psychedelics as cognitive and emotional enhancers.
Rifkin, B. D., Maraver, M. J., & Colzato, L. S. (2020) · Psychology of Consciousness Theory Research and Practice · doi:10.1037/cns0000213 · Cited by 15
Varani, A. M., Silva, S. R., Lopes, S. S. D. S., Barbosa, J. B. F., de Oliveira, D. R., Corrêa, M. A., Moraes, A. P., Miranda, V. F. O., & Prosdocimi, F. (2022) · PeerJ · doi:10.7717/peerj.14114 · Cited by 11
Recent Evidence on the Antidepressant Effects of Ayahuasca
Palhano-Fontes, F., Mota-Rolim, S. A., Soares, B. L., Coelho, N. L. G., Maia‐de‐Oliveira, J. P., & de Araújo, D. B. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_2 · Cited by 12
Simão, A. Y., Gonçalves, J., Caramelo, D., Rosado, T., Barroso, M., Restolho, J., Fernández, N., Rodilla, J. M., Duarte, A. P., Cristóvão, A. C., et al. (2020) · SN Applied Sciences · doi:10.1007/s42452-020-2296-0 · Cited by 10
Cortical structural differences following repeated ayahuasca use hold molecular signatures
Mallaroni, P., Mason, N. L., Kloft, L., Reckweg, J. T., van Oorsouw, K. I. M., & Ramaekers, J. G. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1217079 · Cited by 8
de Vargas, D. M., Bastiani, M. A. D., Parsons, R. B., & Klamt, F. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02203-x · Cited by 9
Fukuyama, Y., Kubo, M., & Harada, K. (2024) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-031-42422-9_1 · Cited by 7
Ayahuasca for the treatment of alcohol use disorder
Marinho, E. A. V., Serra, Y. A., Oliveira-Lima, A. J., Marcourakis, T., & Berro, L. F. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.07.007 · Cited by 10
3-Tetrazolyl-β-carboline derivatives as potential neuroprotective agents
Ribeiro, J., Costa, I., Silva, R. V. D. S., Lopes, S. M. M., Saraiva, L., & Melo, T. M. V. D. P. E. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117841 · Cited by 6
Metadata
- Authors
- Morales-García, J. A., de la Fuente Revenga, M., Alonso-Gil, S., Rodríguez-Franco, M. I., Feilding, A., Perez-Castillo, A., & Riba, J.
- Affiliations
- Beckley Foundation (GB)
- Venue
- Scientific Reports
- Published
- 2017-07-13
- Volume
- 7
- Issue
- 1
- Pages
- 5309-5309
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5509699
- OpenAlex
- W2728001011
- Cited by
- 175
- References
- 70
- Citations by year
- 2026: 15 · 2025: 13 · 2024: 22 · 2023: 19 · 2022: 29 · 2021: 28 · 2020: 26 · 2019: 12 · 2018: 10
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Beckley Foundation
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (SAF2014-52940-R)
- Instituto de Salud Carlos III (SAF2014-52940-R)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and bioactivity of alkaloids
- Keywords
- Banisteriopsis caapi, ayahuasca, harmine, tetrahydroharmine, harmaline, harmol, alkaloids, adult neurogenesis, neural stem cells, neurospheres, hippocampus, antidepressant effects, neuroplasticity, subventricular zone, subgranular zone
- MeSH terms
- Alkaloids, Animals, Cell Differentiation, Cell Movement, Cells, Cultured, Harmaline, Harmine, Neuroprotective Agents, Banisteriopsis, Cell Proliferation, Mice, Neurogenesis, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review